Medscape22m
Two-Drug HIV Regimen Matches Standard of Care Therapy in Absence of Drug Resistance Testing
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
Cancer Therapy Advisor1d
Antibody-Drug Conjugate Proves Active in Ovarian Cancer
A TROP2-directed antibody-drug conjugate, DB-1305/BNT325, demonstrated durable activity in patients with previously treated ovarian cancer in a first-in-human trial. These results were presented at ...
EL PAÍS English4d
The most expensive drug ever approved: A gene therapy that cures butterfly skin and could cost $20 million per patient
Mía had dystrophic epidermolysis bullosa, better known as butterfly skin due to the extreme fragility of this tissue in ...
Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle ...
Michigan boy's death raises concerns about unregulated hyperbaric oxygen therapy
State legislators want greater oversight of the wellness industry after 5-year-old Thomas Cooper was killed in a hyperbaric ...
Medscape4d
New Bifunctional Drug Shows Sustained Effect in Alopecia Areata
In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...
Healthline23h
'White Lotus' Characters Pop Lorazepam Pills, Highlighting Risks of the Drug
In Season 3 of the HBO series "The White Lotus," some characters pop lorazepam like candy, highlighting the potential for ...
pharmaphorum10h
AbbVie builds the case for ovarian cancer drug Elahere
AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...
Rolling Out6d
New drug outperforms therapy for severe food allergies
Clinical trial shows omalizumab (Xolair) treats multiple severe food allergies more effectively than oral immunotherapy, with ...
IIT Roorkee Discovers Potential Drug To Fight Chikungunya And Mosquito-Borne Diseases
IIT Roorkee researchers have discovered that Efavirenz, an HIV drug, may help treat Chikungunya by reducing virus replication in lab tests and mice models. While promising, clinical trials are needed ...
Fierce Pharma6d
Neurotech nabs FDA approval to treat rare eye disorder with cell therapy implant Encelto
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...
Bristol-Myers Squibb To Acquire 2seventy bio - A Sad But Inevitable End To A Cell Therapy Pioneer
Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...